Nasdaq:CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
A digital health platform delivering chronic care management and virtual care solutions to reduce healthcare costs and improve patient outcomes.
Key Metrics
Investment Thesis
Bull Case
Investors may view CLOV as a turnaround play given its massive gross profit of $1.92B which indicates high margin potential once operating leverage is achieved. The company's strong balance sheet with $78.3M in cash and equivalents provides the flexibility to fund growth initiatives or acquire competitors. If the digital health sector matures, CLOVER's established network could position it as a dominant player in chronic care management.
Bear Case
The deteriorating net income trend from -$338.8M in 2022 to -$85.5M in 2025 shows persistent unprofitability that depresses shareholder value. Negative cash flow from operations of -$66.9M combined with a retained earnings deficit of -$2.29B signals severe liquidity and solvency risks. Revenue contraction over the past three years suggests an inability to capture market share effectively against well-funded competitors.
About CLOVER HEALTH INVESTMENTS, CORP. /DE
CLOVER HEALTH INVESTMENTS is a global provider of digital health services focused on chronic care management and virtual care solutions. Operating primarily in the United States and Europe, the company leverages proprietary technology to connect patients with healthcare providers for continuous monitoring and support. Key revenue streams include subscription-based care plans, telehealth services, and data analytics sold to insurers and employers.
Analysis
Management Discussion
Despite generating $1.92B in revenue in 2025, the company reported a net loss of $85.5M, reflecting ongoing investments in technology and clinical expansion. Cash flow from operations was negative at -$66.9M, indicating that operating losses are not yet covered by core business cash generation, though investing cash flow remained positive at $4.1M. The significant reduction in revenue from 2022 to 2024 suggests a challenging market environment or strategic contraction prior to the recent uptick.
Industry Overview
The digital health industry is rapidly evolving as payers shift away from fee-for-service models toward value-based care requiring robust technology platforms. Companies in this space face intense competition from large tech firms and established healthcare systems launching their own telehealth divisions. Success depends on demonstrating clear cost savings and improved patient outcomes to justify high customer acquisition costs.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $3.48B | $2.03B | $1.37B | $1.92B |
| Cost of Revenue | $3.45B | $1.78B | $0 | $0 |
| Gross Profit | $22.7M | $257.3M | $1.37B | $1.92B |
| Operating Expenses | $3.85B | $2.24B | $1.42B | $2.01B |
| Operating Income | $-370.9M | $-208.5M | $-45.7M | $-85.5M |
| G&A | $207.9M | $187.6M | $176.5M | $214.3M |
| Stock-Based Comp | $164.3M | $140.9M | $114.3M | $103.7M |
| D&A | $1.2M | $2.5M | $1.3M | $1.7M |
| Depreciation | $400.0K | $400.0K | $200.0K | $200.0K |
| Amortization | $100.0K | — | — | — |
| Other OpEx | $3.64B | $2.05B | $1.24B | $1.80B |
| Non-Operating Income | $0 | $0 | $-517.0K | $-20.0K |
| Interest Expense | $1.3M | $7.0K | — | — |
| Pre-Tax Income | $-370.9M | $-208.5M | $-46.3M | $-85.5M |
| Income Tax | $0 | $0 | $0 | $0 |
| Continuing Ops | $-370.9M | $-208.5M | $-46.3M | $-85.5M |
| Discontinued Ops | $0 | $0 | $3.3M | $0 |
| Net Income | $-338.8M | $-213.4M | $-43.0M | $-85.5M |
| Minority Interest | $0 | $0 | $0 | $0 |
| Net to Common | $-338.8M | $-213.4M | $-43.0M | $-85.5M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current Assets | $625.0M | $428.0M | $343.1M | $307.9M |
| Cash & Equivalents | $103.8M | $122.9M | $194.5M | $78.3M |
| Other Current Assets | $521.2M | $305.1M | $148.6M | $229.6M |
| Long-Term Assets | $183.6M | $142.7M | $237.6M | $233.2M |
| PP&E (Net) | $5.8M | $5.1M | $5.3M | $6.4M |
| Goodwill | $11.7M | $0 | — | — |
| Operating Leases | $4.0M | $3.4M | — | — |
| Other LT Assets | $162.1M | $134.2M | $232.3M | $226.8M |
| Total Assets | $808.6M | $570.7M | $580.7M | $541.0M |
| Current Liabilities | $440.7M | $261.1M | $213.5M | $208.8M |
| Current Leases | $1.8M | $1.7M | — | — |
| Deferred Revenue | — | $3.1M | — | — |
| Other Current Liab | $438.8M | $256.4M | — | — |
| Long-Term Liabilities | $20.2M | $23.2M | $26.1M | $23.5M |
| Long-Term Debt | $0 | — | — | — |
| LT Operating Leases | $4.0M | $3.0M | — | — |
| Other LT Liab | $16.2M | $20.2M | — | — |
| Total Liabilities | $460.9M | $284.3M | $239.6M | $232.3M |
| Shareholders' Equity | $347.7M | $286.4M | $341.1M | $308.7M |
| Paid-In Capital | $2.32B | $2.46B | $2.58B | $2.68B |
| Retained Earnings | $-1.96B | $-2.16B | $-2.20B | $-2.29B |
| AOCI | $-9.4M | $-2.4M | $-1.6M | $528.0K |
| Total L&E | $808.6M | $570.7M | $580.7M | $541.0M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $-338.8M | $-213.4M | $-43.0M | $-85.5M |
| Non-Cash Adjustments | $60.6M | $154.7M | $117.2M | $-8.6M |
| Working Capital Changes | $74.3M | $-57.2M | $-39.3M | $27.2M |
| Cash from Operations | $-203.9M | $-115.9M | $34.8M | $-66.9M |
| Capital Expenditures | $4.5M | $584.0K | $1.6M | $2.0M |
| Cash from Investing | $95.1M | $140.0M | $565.0K | $4.1M |
| Share Buybacks | $6.4M | $6.2M | $1.8M | $18.3M |
| Cash from Financing | $-5.0M | $-33.9M | $-17.4M | $-53.4M |
| FX Effect | $0 | $0 | $0 | $0 |
| Net Change in Cash | $-113.8M | $-9.7M | $18.0M | $-116.2M |
| Beginning Cash | $300.0M | $186.2M | $176.5M | $194.5M |
| Ending Cash | $186.2M | $176.5M | $194.5M | $78.3M |
Frequently Asked Questions
How does CLOVER HEALTH INVESTMENTS, CORP. /DE make money?
The company derives revenue from two primary segments: Care Management Services, which includes chronic disease programs like diabetes and heart failure, and Virtual Care Services, encompassing telehealth visits and remote patient monitoring. A third segment involves the sale of proprietary software and data analytics to healthcare systems and payers seeking to optimize operational efficiency.
What are the main risks for CLOV?
Significant volatility in revenue driven by contract renewals and the competitive landscape of digital health is a primary concern. The company operates with substantial operating losses and a large retained earnings deficit, raising questions about long-term sustainability without new capital. Heavy reliance on third-party payer contracts creates concentration risk if major insurers reduce spending or terminate agreements. Rising regulatory scrutiny on telehealth reimbursement and data privacy laws could impact future growth.
What is CLOV's competitive advantage?
CLOVER HEALTH boasts a proprietary digital platform that integrates seamlessly with electronic health records, ensuring high adoption rates among providers. The company's specialized clinical teams deliver superior patient engagement metrics compared to industry peers, leading to better health outcomes. Their extensive network of certified healthcare professionals allows for rapid scaling of care delivery across multiple geographies.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.